EUCTR2015-001235-20-GB进行中(未招募)1 期
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease - PASTIS
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. Radiological evidence of cerebral small vessel disease defined as: MRI evidence of lacunar infarct(s) (= 1.5 cm maximum diameter) and/or confluent deep white matter leukoaraiosis (= grade 2 on Fazekas scale)
- •2. Clinical evidence of cerebral small vessel disease can be:
- •a) lacunar stroke syndrome with symptoms lasting >24 hours, occurring at least 6 months previously; OR:
- •b) transient ischaemic attack lasting < 24 hours with limb weakness, hemi-sensory loss or dysarthria at least 6 months previously AND with MRI DWI performed acutely showing lacunar infarction, OR if MRI is not performed within 10 days of TIA, a lacunar infarction in an anatomically appropriate position is demonstrated on a subsequent MRI
- •3. Age = 55 years.
- •4. Imaging of the carotid arteries with Doppler ultrasound, CT
- •angiography or MR angiography in the previous 12 months,
- •demonstrating < 70% stenosis in both internal carotid arteries
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 34
排除标准
- •1. Known diagnosis of dementia
- •2. Cortical infarction (>1.5 cm maximum diameter)
- •3. Systolic BP <90 and/or diastolic BP < 50
- •4. Creatinine Clearance<50ml/min
- •5. Severe hepatic impairment
- •6. History of Lactose intolerance
- •7. Concomitant use of PDE5 inhibitors e.g. sildenafil, tadalafil, vardenafil.
- •8. Concomitant use of alpha-blockers e.g. alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, and terazosin can all increase the risk of postural hypotension.
- •9.Participants receiving nicorandil and nitrates e.g. isosorbide mononitrate, isosorbide dinitrate, glyceryl trinitrate
- •10. weight > 130kg
- •11 Uncontrolled cardiac failure
- •12. Persistent or paroxysmal atrial fibrillation
- •13. History of gastric ulceration
- •14. History of ‘sick sinus syndrome’ or other supraventricular cardiac conduction conditions such as sinoatrial or atrioventricular block
- •15. Uncontrolled COPD
- •16. Stroke or TIA within the last 6 months
- •17. MRI not tolerated or contra-indicated : MRI exclusion criteria -Participant has a cardiac pacemaker; recent surgery; vascular clips; metal implants or joint replacements; have had metal fragments in their eyes; has ever worked on a lathe; has shrapnel from a war injury; possibility of pregnancy
- •18. Known monogenic causes of stroke e.g.. CADASIL
- •19 Unable to provide informed consent
- •20. enrolled in another CTIMP study.
研究者
相似试验
招募中
不适用
Perfusion imaging by arterial spin labelling for clinical use in strokeI65.2I66.0I63.2I63.5Occlusion and stenosis of carotid arteryOcclusion and stenosis of middle cerebral arteryCerebral infarction due to unspecified occlusion or stenosis of precerebral arteriesCerebral infarction due to unspecified occlusion or stenosis of cerebral arteriesDRKS00003198Charité Campus Charité Mitte81
已完成
不适用
An effectiveness of arterial spin labeling perfusion MRI combined with contrast MRI for determination of tumor typessMetastatic brain tumor Glioma LymphomaJPRN-UMIN000018485Tokushima university100
撤回
不适用
Serial arterial spin labeling perfusion MRI in acute ischemic stroke: detecting incomplete microvascular reperfusion.NL-OMON47938Erasmus MC, Universitair Medisch Centrum Rotterdam20
已完成
不适用
Cerebral perfusion, measured by Arterial Spin Labeling (ASL) perfusion MRI, in relation to outcome in children and young adults with ischaemic strokeischaemic stroke1000796310003216strokeNL-OMON31120niversitair Medisch Centrum Utrecht80
已完成
不适用
Arterial spin labelling for the assessment of cerebral autoregulation - a proof of principledementiaAlzheimer's DiseaseNL-OMON42505Radboudumc15
